Clinical Trial Update: Effectiveness of Empagliflozin Added to Automated Insulin Delivery (AID) Systems in Adults With Type 1 Diabetes With Sub-optimal Glycemic Outcomes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the effectiveness of adding empagliflozin to automated insulin delivery systems in adults with Type 1 diabetes and suboptimal g…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Jardiance (empagliflozin)

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Type 1 Diabetes | Phase 4 | Status: RECRUITING